Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 31 to 45 of 124 results for rheumatoid arthritis

  1. Manchester Royal Infirmary Virtual Biologics Clinic

    experience, and maximise research opportunities for patients with rheumatoid arthritis (RA) and related diseases. The service includes...

  2. Empowering patients to be their own personal trainers to improve function and strength - Implementing NICE NG100

    Hospital provides specialised exercise provision for patients with rheumatoid arthritis (RA). This gym-based programme educates patients...

  3. Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip (TA304)

    Evidence-based recommendations on artificial hips and hip resurfacing for treating end-stage arthritis of the hip in adults.

  4. Molnupiravir for treating COVID-19 [ID6340]

    In development [GID-TA11409] Expected publication date: 29 January 2025

  5. Rheumatology referral prioritisation: the right care in the right place at the right time

    prioritisation service aligns with NICE guidance for the management of rheumatoid arthritis in adults (NG100), particularly...

  6. Further primary research is recommended on the clinical effectiveness of using ELISA tests for therapeutic monitoring of TNF‑alpha inhibitors in people with rheumatoid arthritis.

    for therapeutic monitoring of TNF‑alpha inhibitors in people with rheumatoid arthritis. Any explanatory notes(if applicable) Source...

  7. Secondary research is recommended to understand the comparative performance of different ELISA tests for therapeutic monitoring of tumour necrosis factor (TNF)‑alpha inhibitors in rheumatoid arthritis

    therapeutic monitoring of tumour necrosis factor (TNF)‑alpha inhibitors in rheumatoid arthritis Any explanatory notes(if applicable)...

  8. Spondyloarthritis (QS170)

    This quality standard covers diagnosing and managing spondyloarthritis in adults aged 16 and over. It describes high-quality care in priority areas for improvement.

  9. Skin involvement in systemic sclerosis: rituximab (ES7)

    Summary of the evidence on rituximab (MabThera) for treating skin involvement in systemic sclerosis to inform local NHS planning and decision-making

  10. Sipavibart for preventing COVID-19 [ID6282]

    In development [GID-TA11352] Expected publication date: 26 February 2025

  11. Integrating service, audit and research data to improve patient care

    NICE Quality Standard QS33 sets benchmarks for the management of rheumatoid arthritis (RA) which have recently been the subject of a...

  12. Golimumab for the treatment of psoriatic arthritis (TA220)

    Evidence-based recommendations on golimumab (Simponi) for treating psoriatic arthritis in adults.

  13. Analgesics:- What is the clinical and cost effectiveness of analgesic drugs other than non-steroidal antiinflammatory drugs (NSAIDs) in adults with rheumatoid arthritis (RA) whose pain or stiffness control is not adequate?

    than non-steroidal antiinflammatory drugs (NSAIDs) in adults with rheumatoid arthritis (RA) whose pain or stiffness control is not...

  14. Weight management: BMI recording (long-term conditions) (IND151)

    This indicator covers the percentage of patients with coronary heart disease, stroke or TIA, diabetes, hypertension, peripheral arterial disease, heart failure, COPD, asthma and/or rheumatoid arthritis who have had a BMI recorded in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM121